Literature DB >> 41930

Plasma binding of benzodiazepines in humans.

R F Johnson, S Schenker, R K Roberts, P V Desmond, G R Wilkinson.   

Abstract

Plasma binding of chlordiazepoxide, diazepam, loraxepam, and oxazepam was determined by equilibrium dialysis in 20 male, healthy volunteers, 25-86 years old. A wide range of binding was observed, with the free fraction varying twofold for lorazepam, fourfold for chlordiazepoxide and diazepam, and over 20-fold for oxazepam. Statistically significant linear relationships were not observed between the degree of binding and age, serum albumin, or total protein for any of the drugs. There was, however, a correlation between the extent of binding for the four drugs. Because of the importance of unbound benzodiazepine levels in eliciting any pharmacological response and also in disposition, consideration of the wide interindividual variability in plasma binding must be made in interpreting pharmacodynamic and pharmacokinetic data.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 41930     DOI: 10.1002/jps.2600681034

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

Review 1.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

2.  Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects.

Authors:  Paul K L Chin; Berit P Jensen; Helle S Larsen; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

3.  Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation.

Authors:  R K Dubey; C B McAllister; M Inoue; G R Wilkinson
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 4.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

5.  Lack of effect of nizatidine on hepatic drug metabolism in man.

Authors:  J W Secor; K V Speeg; C G Meredith; R F Johnson; P Snowdy; S Schenker
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

6.  Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam.

Authors:  E H Ellinwood; D G Heatherly; A M Nikaido; T D Bjornsson; C Kilts
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 7.  Clinical pharmacokinetics of oxazepam and lorazepam.

Authors:  D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

9.  Human placental transport of cimetidine.

Authors:  S Schenker; J Dicke; R F Johnson; L L Mor; G I Henderson
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

10.  Disposition of oxazepam in relation to age, sex, and cigarette smoking.

Authors:  H R Ochs; D J Greenblatt; H Otten
Journal:  Klin Wochenschr       Date:  1981-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.